期刊文献+
共找到1篇文章
< 1 >
每页显示 20 50 100
Developing New Small Molecular Drugs for Prostate Cancer Therapy
1
作者 Tzu-Min Chan Horng-Jyh Harn +1 位作者 Tzyy-Wen Chiou Shinn-Zong Lin 《Journal of Cancer Therapy》 2013年第4期86-90,共5页
Most of the early prostate cancer has no obvious symptoms, but its malignancy metastasis will cause largely deaths. The treatment options for patients with prostate cancer include traditional surgery, external beam th... Most of the early prostate cancer has no obvious symptoms, but its malignancy metastasis will cause largely deaths. The treatment options for patients with prostate cancer include traditional surgery, external beam therapy, hormone therapy, small molecular drug and cryosurgery. It was considered non-traditional treatments also can be used in alternative medicines for prostate cancer therapy. There are well-known molecular mechanisms and their pathogenesis, which provide potential targets for drug screening on the prostate cancer. Currently, natural plant extracts or human tissues active ingredients are widely used for the treatment of cancer. Then isolated effective substances in the extract, and further prepared large amounts of small molecule drugs by chemical synthesis. In this review, we summarized four small molecular drugs, abiraterone, docetaxel, isochaihulactone and butylidenephthalide, and their detailed anti-tumor mechanisms. These indicate that small molecular drug is a very efficient way and can be used for prostate cancer treatment. 展开更多
关键词 PROSTATE Cancer SMALL MOLECULAR DRUGS ABIRATERONE DOCETAXEL Isochaihulactone Butylidenephthalide
下载PDF
上一页 1 下一页 到第
使用帮助 返回顶部